BCAX
Bicara Therapeutics Inc.
$18.48
-$0.37(-1.96%)
52
Overall
60
Value
63
Tech
34
Quality
Market Cap
$1.17B
Volume
2.09M
52W Range
$7.80 - $19.75
Target Price
$32.57
EPS Estimates Overview
| Current Quarter | $-0.72 | Next Quarter | $-0.74 |
| Current Year | $-2.55 | Next Year | $-3.11 |
| QoQ Growth | -2.8% | YoY Growth | -22.0% |
| 3Y EPS CAGR | N/A | Target Price | $32.57 |
| Consensus | Buy | Upside | +76.2% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $18.48 | -2.0% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW